The upregulation and hyperactivation of these GSTs could enhance the catalytic detoxification of anti-cancer drugs and modulate apoptotic signaling, and indeed the level of GSTs is being considered as one of the major causes of MDR in cancer cells (Singh, 2015). Here, HPGDS is linked to cancer.